Trial intelligence / Profile preview

Micafungin prophylaxis in cord blood allo-SCT

NCT01888458Phase 2Completed

Sponsor
CHU de Nantes
Start
Sep 2013
Primary completion
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of micafungin in invasive fungal infection (IFI), sponsored by CHU de Nantes. Started Sep 2013; status: completed.

02

Drugs

micafungin
03

Conditions

invasive fungal infection (IFI)

Beyond the preview

Go deeper on NCT01888458.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01888458.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call